Table 1 |
|||||
|
Summary of GPC3 immunoreactivity. |
|||||
|
0 (< 5% cells stained) |
1+ (5-10% cells stained) |
2+ (11-50% cells stained) |
3+ (> 50% cells stained) |
Mean Intensity |
|
|
|
|||||
|
Placental site trophoblastic tumor (n = 15) |
3 (20%) |
3 (20%) |
6 (40%) |
3 (20%) |
1.3 |
|
|
|||||
|
Placental site nodule (n = 2) |
0 |
1 (50%) |
1 (50%) |
0 |
1.5 |
|
|
|||||
|
Cervical squamous cell carcinoma (n = 7) |
4 (57%) |
2 (29%) |
1 (14%) |
0 |
0.7 |
|
|
|||||
|
Endometrial adenocarcinoma (n = 11) |
11 (100%) |
0 |
0 |
0 |
0 |
|
|
|||||
|
Uterine leiomyoma (n = 1) |
1 (100%) |
0 |
0 |
0 |
0 |
|
|
|||||
|
Leiomyosarcoma (n = 1) |
1 (100%) |
0 |
0 |
0 |
0 |
|
|
|||||
|
Ou-Yang et al. Diagnostic Pathology 2010 5:64 doi:10.1186/1746-1596-5-64 |
|||||
